Correlation Between Aerovate Therapeutics and Raffles Medical
Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and Raffles Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and Raffles Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aerovate Therapeutics and Raffles Medical Group, you can compare the effects of market volatilities on Aerovate Therapeutics and Raffles Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of Raffles Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and Raffles Medical.
Diversification Opportunities for Aerovate Therapeutics and Raffles Medical
-0.61 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Aerovate and Raffles is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and Raffles Medical Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Raffles Medical Group and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with Raffles Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Raffles Medical Group has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and Raffles Medical go up and down completely randomly.
Pair Corralation between Aerovate Therapeutics and Raffles Medical
Given the investment horizon of 90 days Aerovate Therapeutics is expected to generate 7.17 times more return on investment than Raffles Medical. However, Aerovate Therapeutics is 7.17 times more volatile than Raffles Medical Group. It trades about 0.01 of its potential returns per unit of risk. Raffles Medical Group is currently generating about -0.07 per unit of risk. If you would invest 1,700 in Aerovate Therapeutics on September 12, 2024 and sell it today you would lose (1,437) from holding Aerovate Therapeutics or give up 84.53% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 21.37% |
Values | Daily Returns |
Aerovate Therapeutics vs. Raffles Medical Group
Performance |
Timeline |
Aerovate Therapeutics |
Raffles Medical Group |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Aerovate Therapeutics and Raffles Medical Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Aerovate Therapeutics and Raffles Medical
The main advantage of trading using opposite Aerovate Therapeutics and Raffles Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, Raffles Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Raffles Medical will offset losses from the drop in Raffles Medical's long position.Aerovate Therapeutics vs. Adagene | Aerovate Therapeutics vs. Acrivon Therapeutics, Common | Aerovate Therapeutics vs. Rezolute | Aerovate Therapeutics vs. AN2 Therapeutics |
Raffles Medical vs. Pennant Group | Raffles Medical vs. Surgery Partners | Raffles Medical vs. The Ensign Group | Raffles Medical vs. Encompass Health Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |